These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35869438)

  • 1. Comparing statistical methods in assessing the prognostic effect of biomarker variability on time-to-event clinical outcomes.
    Gao F; Luo J; Liu J; Wan F; Wang G; Gordon M; Xiong C
    BMC Med Res Methodol; 2022 Jul; 22(1):201. PubMed ID: 35869438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis.
    Gao F; Miller JP; Miglior S; Beiser JA; Torri V; Kass MA; Gordon MO
    BMC Med Res Methodol; 2012 Oct; 12():151. PubMed ID: 23035867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Joint Model for Prognostic Effect of Biomarker Variability on Outcomes: long-term intraocular pressure (IOP) fluctuation on the risk of developing primary open-angle glaucoma (POAG).
    Gao F; Miller JP; Miglior S; Beiser JA; Torri V; Kass MA; Gordon MO
    JP J Biostat; 2011 May; 5(2):73-96. PubMed ID: 22180704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Primary Open-Angle Glaucoma Prediction Model Using Long-term Intraocular Pressure Variability Data: A Secondary Analysis of 2 Randomized Clinical Trials.
    Gordon MO; Gao F; Huecker JB; Miller JP; Margolis M; Kass MA; Miglior S; Torri V;
    JAMA Ophthalmol; 2020 Jul; 138(7):780-788. PubMed ID: 32496526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Calculation in the Medication Arm of the Ocular Hypertension Treatment Study.
    Leshno A; De Moraes CG; Cioffi GA; Kass M; Gordon M; Liebmann JM
    Ophthalmol Glaucoma; 2023; 6(6):592-598. PubMed ID: 37336266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.
    Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study Group
    Ophthalmology; 2008 Nov; 115(11):2030-6. PubMed ID: 18801578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.
    Clement Freiberg J; von Spreckelsen A; Kolko M; Azuara-Blanco A; Virgili G
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013817. PubMed ID: 35686679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.
    Brandt JD; Gordon MO; Gao F; Beiser JA; Miller JP; Kass MA;
    Ophthalmology; 2012 Mar; 119(3):437-42. PubMed ID: 21705084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk calculation variability over time in ocular hypertensive subjects.
    Song C; De Moraes CG; Forchheimer I; Prata TS; Ritch R; Liebmann JM
    J Glaucoma; 2014 Jan; 23(1):1-4. PubMed ID: 22668983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome.
    Gao F; Miller JP; Xiong C; Beiser JA; Gordon M;
    Stat Methods Appt; 2011 Mar; 20(1):83-100. PubMed ID: 21339862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.
    ; ; Gordon MO; Torri V; Miglior S; Beiser JA; Floriani I; Miller JP; Gao F; Adamsons I; Poli D; D'Agostino RB; Kass MA
    Ophthalmology; 2007 Jan; 114(1):10-9. PubMed ID: 17095090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucoma Risk Alleles in the Ocular Hypertension Treatment Study.
    Scheetz TE; Faga B; Ortega L; Roos BR; Gordon MO; Kass MA; Wang K; Fingert JH
    Ophthalmology; 2016 Dec; 123(12):2527-2536. PubMed ID: 27707548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.
    Levine RA; Demirel S; Fan J; Keltner JL; Johnson CA; Kass MA;
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3896-903. PubMed ID: 16936102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of intraocular pressure and frequency of spontaneous retinal venous pulsation in primary open-angle glaucoma.
    Seo JH; Kim TW; Weinreb RN; Kim YA; Kim M
    Ophthalmology; 2012 Nov; 119(11):2254-60. PubMed ID: 22980741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
    Salvetat ML; Zeppieri M; Tosoni C; Brusini P;
    Eye (Lond); 2016 Jun; 30(6):784-95. PubMed ID: 27174381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
    Kass MA; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish RK; Wilson MR; Gordon MO
    Arch Ophthalmol; 2002 Jun; 120(6):701-13; discussion 829-30. PubMed ID: 12049574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting Glaucoma in the Ocular Hypertension Study Using Deep Learning.
    Fan R; Bowd C; Christopher M; Brye N; Proudfoot JA; Rezapour J; Belghith A; Goldbaum MH; Chuter B; Girkin CA; Fazio MA; Liebmann JM; Weinreb RN; Gordon MO; Kass MA; Kriegman D; Zangwill LM
    JAMA Ophthalmol; 2022 Apr; 140(4):383-391. PubMed ID: 35297959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary open-angle glaucoma in a population associated with high prevalence of primary angle-closure glaucoma: the Kumejima Study.
    Yamamoto S; Sawaguchi S; Iwase A; Yamamoto T; Abe H; Tomita G; Tomidokoro A; Araie M
    Ophthalmology; 2014 Aug; 121(8):1558-65. PubMed ID: 24746386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of open-angle glaucoma with perfusion pressure status in the Thessaloniki Eye Study.
    Topouzis F; Wilson MR; Harris A; Founti P; Yu F; Anastasopoulos E; Pappas T; Koskosas A; Salonikiou A; Coleman AL
    Am J Ophthalmol; 2013 May; 155(5):843-51. PubMed ID: 23394905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.